These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6835564)

  • 1. [Update on antibiotic therapy. 15) A combination of fosfomycin and amoxicillin (penamic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 Mar; 74(13):769-74. PubMed ID: 6835564
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of cofosfolactamine in localized bacterial infections].
    Scalzini A; Chiodera A; Sueri L
    G Ital Chemioter; 1984; 31(1-2):205-6. PubMed ID: 6468828
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
    Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
    Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic prophylaxis with cofosfolactamine in biliary tract surgery: prospective controlled study of different routes of administration].
    Civello IM; De Giovanni L; Reggio D; Destito C; Cotogni P; Butti A
    Chir Patol Sper; 1983 Aug; 31(4):149-55. PubMed ID: 6399894
    [No Abstract]   [Full Text] [Related]  

  • 6. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects].
    Di Nola F; Soranzo ML
    Minerva Med; 1983 Feb; 74(6):239-48. PubMed ID: 6828256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in antibiotic therapy. 14) Fosfomycin].
    Di Nola F
    Minerva Med; 1983 Mar; 74(12):671-5. PubMed ID: 6835557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of cofosfolactamines in subjects with impaired kidney function].
    Bersani C; De Rose V; Grassi G; Mangiarotti P; Santagada T; Uccelli M; Fietta A
    G Ital Chemioter; 1986; 33(2-3):121-8. PubMed ID: 3678716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monural--novel antibiotic of single administration in the treatment of acute cystitis].
    Naber KG
    Akush Ginekol (Sofiia); 2008; 47 Suppl 1():19-21. PubMed ID: 18935853
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of growth in vitro of bacteria from the oral cavity using a combination of fosfomycin and ampicillin].
    Pase U; Tafuro A
    G Stomatol Ortognatodonzia; 1984; 3(3):358-60. PubMed ID: 6599001
    [No Abstract]   [Full Text] [Related]  

  • 12. [One time therapy of urinary tract infections with amoxicillin or co-trimoxazole. A randomized study].
    Wetzel H; Stille W
    Med Welt; 1981 Nov; 32(46):1753-6. PubMed ID: 6975870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monural--new antibiotic with single intake for treatment of acute cystitis].
    Akush Ginekol (Sofiia); 2008; 47(4):56. PubMed ID: 19227768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lower urinary tract infections: bacterial epidemiology and recommendations].
    Bergogne-Bérézin E
    Prog Urol; 2008 Feb; 18(1 Suppl FMC):F11-4. PubMed ID: 18773847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentin-nice idea, but more trials please.
    Drug Ther Bull; 1982 Mar; 20(6):21-3. PubMed ID: 7075472
    [No Abstract]   [Full Text] [Related]  

  • 16. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fosfomycin. II. Antimicrobial activity in vivo].
    Carlone NA; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1977; 70(7-12):215-25. PubMed ID: 615746
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of Augmentin and co-trimoxazole in the treatment of adult infections in general practice.
    Davies JG; Rose AJ; Walker GD
    Br J Clin Pract; 1982 Dec; 36(11-12):387-93, 403. PubMed ID: 6984654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fosfomycin].
    Gobernado M
    Rev Esp Quimioter; 2003 Mar; 16(1):15-40. PubMed ID: 12750755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.